Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectinZhijie Zhang(China Pharmaceutical University), Meijia YangJournal for ImmunoTherapy of CancerAugust 1, 202310.1136/jitc-2023-007199Cited by 12SaveCiteExport RISWatch citationsRelated PapersHyperbaric Oxygen Boosts PD‐1 Antibody Delivery and T Cell Infiltration for Augmented Immune Responses Against Solid Tumors|Advanced Science|2021|84Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression|Molecular Pain|2025|0